We observed an increasing trend in CD44 expressions as a marker of antigen experience in the CD8 + T cells, which mounted a protective response against the SARS-CoV-2 ( Figure 2 B, Supplementary Figure S1A ) [ 41 ].
← all excerpts
A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations.
1
—
—